Skip to main content
Top
Published in: AIDS and Behavior 2/2017

01-02-2017 | Original Paper

Factors Associated with HIV Testing Among Participants from Substance Use Disorder Treatment Programs in the US: A Machine Learning Approach

Authors: Yue Pan, Hongmei Liu, Lisa R. Metsch, Daniel J. Feaster

Published in: AIDS and Behavior | Issue 2/2017

Login to get access

Abstract

HIV testing is the foundation for consolidated HIV treatment and prevention. In this study, we aim to discover the most relevant variables for predicting HIV testing uptake among substance users in substance use disorder treatment programs by applying random forest (RF), a robust multivariate statistical learning method. We also provide a descriptive introduction to this method for those who are unfamiliar with it. We used data from the National Institute on Drug Abuse Clinical Trials Network HIV testing and counseling study (CTN-0032). A total of 1281 HIV-negative or status unknown participants from 12 US community-based substance use disorder treatment programs were included and were randomized into three HIV testing and counseling treatment groups. The a priori primary outcome was self-reported receipt of HIV test results. Classification accuracy of RF was compared to logistic regression, a standard statistical approach for binary outcomes. Variable importance measures for the RF model were used to select the most relevant variables. RF based models produced much higher classification accuracy than those based on logistic regression. Treatment group is the most important predictor among all covariates, with a variable importance index of 12.9%. RF variable importance revealed that several types of condomless sex behaviors, condom use self-efficacy and attitudes towards condom use, and level of depression are the most important predictors of receipt of HIV testing results. There is a non-linear negative relationship between count of condomless sex acts and the receipt of HIV testing. In conclusion, RF seems promising in discovering important factors related to HIV testing uptake among large numbers of predictors and should be encouraged in future HIV prevention and treatment research and intervention program evaluations.
Literature
2.
go back to reference Hall HI, An Q, Tang T, et al. Prevalence of diagnosed and undiagnosed HIV infection—United States, 2008–2012. MMWR Morb Mortal Wkly Rep. 2015;26:657–62. Hall HI, An Q, Tang T, et al. Prevalence of diagnosed and undiagnosed HIV infection—United States, 2008–2012. MMWR Morb Mortal Wkly Rep. 2015;26:657–62.
4.
go back to reference Hall HI, Holtgrave DR, Maulsby C. HIV transmission rates from persons living with HIV who are aware and unaware of their infection. AIDS. 2012;26(7):893–6.CrossRefPubMed Hall HI, Holtgrave DR, Maulsby C. HIV transmission rates from persons living with HIV who are aware and unaware of their infection. AIDS. 2012;26(7):893–6.CrossRefPubMed
5.
go back to reference Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR. Recommendations and reports: morbidity and mortality weekly report. Recommendations and reports/Centers for Disease Control. 2006;55(RR-14):1–17; quiz CE11-14. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR. Recommendations and reports: morbidity and mortality weekly report. Recommendations and reports/Centers for Disease Control. 2006;55(RR-14):1–17; quiz CE11-14.
6.
go back to reference Centers for Disease Control and Prevention (CDC). Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the US Department of Health and Human Services. MMWR. Recommendations and reports: morbidity and mortality weekly report. Recommendations and reports/Centers for Disease Control. 2012;61(RR-5):1. Centers for Disease Control and Prevention (CDC). Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the US Department of Health and Human Services. MMWR. Recommendations and reports: morbidity and mortality weekly report. Recommendations and reports/Centers for Disease Control. 2012;61(RR-5):1.
9.
go back to reference King KM, Nguyen HV, Kosterman R, Bailey JA, Hawkins JD. Co-occurrence of sexual risk behaviors and substance use across emerging adulthood: evidence for state- and trait-level associations. Addiction. 2012;107(7):1288–96.CrossRefPubMedPubMedCentral King KM, Nguyen HV, Kosterman R, Bailey JA, Hawkins JD. Co-occurrence of sexual risk behaviors and substance use across emerging adulthood: evidence for state- and trait-level associations. Addiction. 2012;107(7):1288–96.CrossRefPubMedPubMedCentral
10.
go back to reference Raj A, Saitz R, Cheng DM, Winter M, Samet JH. Associations between alcohol, heroin, and cocaine use and high risk sexual behaviors among detoxification patients. Am J Drug Alcohol Abuse. 2007;33(1):169–78.CrossRefPubMed Raj A, Saitz R, Cheng DM, Winter M, Samet JH. Associations between alcohol, heroin, and cocaine use and high risk sexual behaviors among detoxification patients. Am J Drug Alcohol Abuse. 2007;33(1):169–78.CrossRefPubMed
11.
go back to reference Rosengard C, Anderson BJ, Stein MD. Correlates of condom use and reasons for condom non-use among drug users. Am J Drug Alcohol Abuse. 2006;32(4):637–44.CrossRefPubMed Rosengard C, Anderson BJ, Stein MD. Correlates of condom use and reasons for condom non-use among drug users. Am J Drug Alcohol Abuse. 2006;32(4):637–44.CrossRefPubMed
12.
go back to reference D’Aunno T, Pollack HA, Jiang L, Metsch LR, Friedmann PD. HIV testing in the nation’s opioid treatment programs, 2005-2011: the role of state regulations. Health Serv Res. 2014;49(1):230–48.CrossRefPubMed D’Aunno T, Pollack HA, Jiang L, Metsch LR, Friedmann PD. HIV testing in the nation’s opioid treatment programs, 2005-2011: the role of state regulations. Health Serv Res. 2014;49(1):230–48.CrossRefPubMed
13.
go back to reference Substance abuse and mental health services Administration, Center for Behavioral Health Statistics and Quality. The N-SSATS report: HIV services offered by substance abuse treatment facilities. Rockville, M.D: Substance Abuse and Mental Health Services Administration; 2010. Substance abuse and mental health services Administration, Center for Behavioral Health Statistics and Quality. The N-SSATS report: HIV services offered by substance abuse treatment facilities. Rockville, M.D: Substance Abuse and Mental Health Services Administration; 2010.
14.
go back to reference Metsch LR, Feaster DJ, Gooden L, et al. Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial. Am J Public Health. 2012;102(6):1160–7.CrossRefPubMedPubMedCentral Metsch LR, Feaster DJ, Gooden L, et al. Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial. Am J Public Health. 2012;102(6):1160–7.CrossRefPubMedPubMedCentral
15.
go back to reference Metcalf CA, Douglas JM Jr, Malotte CK, et al. Relative efficacy of prevention counseling with rapid and standard HIV testing: a randomized, controlled trial (RESPECT-2). Sex Transm Dis. 2005;32(2):130–8.CrossRefPubMed Metcalf CA, Douglas JM Jr, Malotte CK, et al. Relative efficacy of prevention counseling with rapid and standard HIV testing: a randomized, controlled trial (RESPECT-2). Sex Transm Dis. 2005;32(2):130–8.CrossRefPubMed
16.
go back to reference Skinner HA. Assessment of substance abuse: drug abuse screening test. 2nd ed. Durham: Macmillan Reference USA; 2001. Skinner HA. Assessment of substance abuse: drug abuse screening test. 2nd ed. Durham: Macmillan Reference USA; 2001.
18.
go back to reference NIAAA. Helping patients who drink too much: a clinician’s guide. Maryland: Bethesda; 2005. NIAAA. Helping patients who drink too much: a clinician’s guide. Maryland: Bethesda; 2005.
19.
go back to reference Koblin BA, Husnik MJ, Colfax G, et al. Risk factors for HIV infection among men who have sex with men. Aids. 2006;20(5):731–9.CrossRefPubMed Koblin BA, Husnik MJ, Colfax G, et al. Risk factors for HIV infection among men who have sex with men. Aids. 2006;20(5):731–9.CrossRefPubMed
20.
go back to reference Metsch LR, McCoy CB, McCoy HV, et al. HIV-related risk behaviors and seropositivity among homeless drug-abusing women in Miami, Florida. J Psychoact Drugs. 1995;27(4):435–46.CrossRef Metsch LR, McCoy CB, McCoy HV, et al. HIV-related risk behaviors and seropositivity among homeless drug-abusing women in Miami, Florida. J Psychoact Drugs. 1995;27(4):435–46.CrossRef
21.
go back to reference Brafford LJ, Beck KH. Development and validation of a condom self-efficacy scale for college students. J Am Coll Health. 1991;39(5):219–25.CrossRefPubMed Brafford LJ, Beck KH. Development and validation of a condom self-efficacy scale for college students. J Am Coll Health. 1991;39(5):219–25.CrossRefPubMed
22.
go back to reference DeHart DD, Birkimer JC. Trying to practice safer sex: development of the sexual risks scale. J Sex Res. 1997;34(1):11–25.CrossRef DeHart DD, Birkimer JC. Trying to practice safer sex: development of the sexual risks scale. J Sex Res. 1997;34(1):11–25.CrossRef
23.
go back to reference Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573–83.CrossRefPubMed Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573–83.CrossRefPubMed
25.
go back to reference Ishwaran H, Kogalur UB, Blackstone EH, Lauer MS. Random survival forests. Ann Appl Stat. 2008;2:841–60.CrossRef Ishwaran H, Kogalur UB, Blackstone EH, Lauer MS. Random survival forests. Ann Appl Stat. 2008;2:841–60.CrossRef
26.
go back to reference Ishwaran H, Kogalur UB. Random forests for survival, regression and classification (RF-SRC), R package version 1.6.1. 2015. Ishwaran H, Kogalur UB. Random forests for survival, regression and classification (RF-SRC), R package version 1.6.1. 2015.
27.
go back to reference Xu, Ruo. “Improvements to random forest methodology”. Graduate Theses and Dissertations. 2013;Paper 13052. Xu, Ruo. “Improvements to random forest methodology”. Graduate Theses and Dissertations. 2013;Paper 13052.
28.
go back to reference Friedman JH. Greedy function approximation: a gradient boosting machine. Ann Stat. 2001;29:1189–232.CrossRef Friedman JH. Greedy function approximation: a gradient boosting machine. Ann Stat. 2001;29:1189–232.CrossRef
29.
go back to reference Ishwaran H. Variable importance in binary regression trees and forests. Electron J Stat. 2007;1:519–37.CrossRef Ishwaran H. Variable importance in binary regression trees and forests. Electron J Stat. 2007;1:519–37.CrossRef
31.
go back to reference Shi M, He J. SNRFCB: sub-network based random forest classifier for predicting chemotherapy benefit on survival for cancer treatment. Mol BioSyst. 2016;12(4):1214–23.CrossRefPubMed Shi M, He J. SNRFCB: sub-network based random forest classifier for predicting chemotherapy benefit on survival for cancer treatment. Mol BioSyst. 2016;12(4):1214–23.CrossRefPubMed
32.
go back to reference Xiao LH, Chen PR, Gou ZP, et al. Prostate cancer prediction using the random forest algorithm that takes into account transrectal ultrasound findings, age, and serum levels of prostate-specific antigen. Asian J Androl. 2016. Xiao LH, Chen PR, Gou ZP, et al. Prostate cancer prediction using the random forest algorithm that takes into account transrectal ultrasound findings, age, and serum levels of prostate-specific antigen. Asian J Androl. 2016.
33.
go back to reference Stekhoven DJ, Bühlmann P. MissForest—non-parametric missing value imputation for mixed-type data. Bioinformatics. 2012;28(1):112–8.CrossRefPubMed Stekhoven DJ, Bühlmann P. MissForest—non-parametric missing value imputation for mixed-type data. Bioinformatics. 2012;28(1):112–8.CrossRefPubMed
34.
go back to reference Noar SM, Cole C, Carlyle K. Condom use measurement in 56 studies of sexual risk behavior: review and recommendations. Arch Sex Behav. 2006;35(3):327–45.CrossRefPubMed Noar SM, Cole C, Carlyle K. Condom use measurement in 56 studies of sexual risk behavior: review and recommendations. Arch Sex Behav. 2006;35(3):327–45.CrossRefPubMed
35.
go back to reference Fonner VA, Kennedy CE, O’Reilly KR, Sweat MD. Systematic assessment of condom use measurement in evaluation of HIV prevention interventions: need for standardization of measures. AIDS Behav. 2014;18(12):2374–86.CrossRefPubMedPubMedCentral Fonner VA, Kennedy CE, O’Reilly KR, Sweat MD. Systematic assessment of condom use measurement in evaluation of HIV prevention interventions: need for standardization of measures. AIDS Behav. 2014;18(12):2374–86.CrossRefPubMedPubMedCentral
36.
go back to reference Schroder KE, Carey MP, Vanable PA. Methodological challenges in research on sexual risk behavior: II. Accuracy of self-reports. Ann Behav Med. 2003;26(2):104–23.CrossRefPubMedPubMedCentral Schroder KE, Carey MP, Vanable PA. Methodological challenges in research on sexual risk behavior: II. Accuracy of self-reports. Ann Behav Med. 2003;26(2):104–23.CrossRefPubMedPubMedCentral
37.
go back to reference Segal MR, Barbour JD, Grant RM. Relating HIV-1 sequence variation to replication capacity via trees and forests. Stat Appl Genet Mol Biol. 2004;3(1):1–18. Segal MR, Barbour JD, Grant RM. Relating HIV-1 sequence variation to replication capacity via trees and forests. Stat Appl Genet Mol Biol. 2004;3(1):1–18.
38.
go back to reference Xu S, Huang X, Xu H, Zhang C. Improved prediction of coreceptor usage and phenotype of HIV-1 based on combined features of V3 loop sequence using random forest. J Microbiol. 2007;45(5):441–6.PubMed Xu S, Huang X, Xu H, Zhang C. Improved prediction of coreceptor usage and phenotype of HIV-1 based on combined features of V3 loop sequence using random forest. J Microbiol. 2007;45(5):441–6.PubMed
Metadata
Title
Factors Associated with HIV Testing Among Participants from Substance Use Disorder Treatment Programs in the US: A Machine Learning Approach
Authors
Yue Pan
Hongmei Liu
Lisa R. Metsch
Daniel J. Feaster
Publication date
01-02-2017
Publisher
Springer US
Published in
AIDS and Behavior / Issue 2/2017
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-016-1628-y

Other articles of this Issue 2/2017

AIDS and Behavior 2/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.